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Background: In elderly patients chronic kidney disease often limits drug prescription. As several equations for quick
assessment of kidney function by estimating glomerular filtration rate (eGFR) and several different clinical
recommendations for drug dose adjustment in renal failure are published, choosing the correct approach for drug
dosage is difficult for the practitioner. The aims of our study were to quantify the agreement between eGFR-equations
grouped by creatinine-based or cystatin C-based and within the groups of creatinine and cystatin C-based equations
and to investigate whether use of various literature and online references results in different recommendations for drug
dose adjustment in renal disease in very elderly primary care patients.
Methods: We included 108 primary care patients aged 80 years and older from 11 family practices into a cross-
sectional study. GFR was estimated using two serum creatinine-based equations (Cockroft-Gault, MDRD) and three
serum cystatin C-based equations (Grubb, Hoek, Perkins). Concordance between different equations was quantified
using intraclass correlation coefficients (ICCs). Essential changes in drug doses or discontinuation of medication were
documented and compared in terms of estimated renal function as a consequence of the different eGFR-equations
using five references commonly used in the US, Great Britain and Germany.
Results: In general, creatinine-based equations resulted in lower eGFR-estimation and in higher necessity of drug dose
adjustment than cystatin C-based equations. Concordance was high between creatinine-based equations alone (ICCs
0.87) and between cystatin C-based equations alone (ICCs 0.90 to 0.96), and moderate between creatinine-based
equations and cystatin C-based equations (ICCs 0.54 to 0.76). When comparing the five different references consulted
to identify necessary drug dose adjustments we found that the numbers of drugs that necessitate dose adjustment in
the case of renal impairment differed considerably. The mean number of recommended changes in drug dosage
ranged between 1.9 and 2.5 per patient depending on the chosen literature reference.
Conclusions: Our data suggest that the choice of the literature source might have even greater impact on drug
management than the choice of the equation used to estimate GFR alone. Efforts should be deployed to standardize
methods for estimating kidney function in geriatric patients and literature recommendations on drug dose adjustment
in renal failure.
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Literature referencesBackground
Family physicians see elderly multimorbid patients re-
ceiving a multiplicity of drugs on a daily basis. In many
of these patients chronic kidney disease is complicating
drug prescription. Family physicians are faced with the
challenge to decide how to best measure renal function* Correspondence: karsch@lrz.tum.de
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distribution, and reproduction in any mediumand draw conclusions for drug dose adjustment. It is es-
sential that kidney function is assessed correctly and that
drug doses are adjusted according to kidney function.
Without drug dose adjustment in the case of impaired
kidney function resulting in reduced drug clearance,
drugs would accumulate and patients would be exposed
to the risk of toxicity and adverse drug reactions. There-
fore kidney function must not be overestimated. On the
other hand, underestimation of kidney function couldtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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potentially essential drugs.
If serum-creatinine is used alone for drug dose adjust-
ment without calculating an estimated glomerular filtra-
tion rate (eGFR), patients are exposed to an increased
risk of adverse drug reactions, because renal function
can be considerably impaired despite normal serum-
creatinine [1]. Serum creatinine-based equations for cal-
culating an eGFR are important tools for identifying
geriatric patients with chronic kidney disease (CKD) and
for allocating appropriate drug dosage in these patients
[2]. The most commonly used serum creatinine-based
GFR or creatinine clearance prediction equations are the
abbreviated (4-variable) Modification of Diet in Renal
Disease (MDRD) [3] and the Cockroft Gault (CG) for-
mula [4]. However, several authors point out that CG
and MDRD have insufficient precision. MDRD is not
suitable for identifying patients with early or moderate
stages of disease, and CG tends to underestimate kidney
function, especially in the elderly. Therefore these for-
mulas should only be used with caution for drug dose
adjustment in the elderly [5-8].
An alternative marker for kidney function is serum
cystatin C, which has been widely examined and com-
pared with the diagnostic use of serum creatinine.
According to two meta-analyses the diagnostic accuracy
of cystatin C for impaired renal function ranges between
slightly and clearly better than the diagnostic accuracy of
creatinine [9,10]. Especially in elderly patients, cystatin
C appears to be a suitable marker for assessing renal
function because there is evidence that it is less sensitive
to metabolic and extra renal factors than creatinine [11].
There are a large number of cystatin C-based equations
for estimating GFR. Several of these have been evaluated
in elderly patients in comparison to a reference standard.
Hojs et al. [12] showed, in an analysis of 234 patients
aged 65 years and older, that serum creatinine-based for-
mulas (i.e. MDRD-4-variable) had slightly lower diagnos-
tic accuracy than cystatin C-based formulas using
51CrEDTA clearance as a reference standard. The Hoek-
formula [13] had the highest accuracy and the Grubb-
formula [14] and the Perkins-formula (Simple Cystatin
C formula) [15], showed reasonable accuracy compared
to 51CrEDTA clearance. A German study examined if
there was a sufficient drug dose adjustment according to
the results of several eGFR-equations based on cystatin
C or creatinine in patients 60 years and older who were
treated by an emergency physician. The number of pa-
tients without appropriate dose adjustment according to
kidney function varied considerably depending on the
equation used for calculating eGFR. This was because
eGFR values themselves differed notably [16]. Swedish
researchers investigated renal function in patients living
in nursing homes aged 65 years and older using the CG,MDRD and Grubb equation and identified renal risk
drugs. Here the authors found poor concordance be-
tween the results of different eGFR equations [17].
For patients with impaired renal function, changes in
drug prescription are required. Numerous literature ref-
erences for drug dose adjustment in renal impairment
are commonly used in family practice in different coun-
tries. Family practitioners rely on literature that can eas-
ily be used in office or at the bedside such as small
books or handheld devices [18-22].
The multitude of eGFR-equations based on serum cre-
atinine or serum cystatin C that have been proposed and
the variety of literature sources for drug dose adjustment
in renal failure have resulted in uncertainty in daily prac-
tice about which method of estimating kidney function
and which literature source should be used.
The aims of our study were
1) to quantify the agreement between eGFR-equations
grouped by creatinine-based or cystatin C-based and
within the groups of creatinine and cystatin C-based
equations and
2) to investigate whether the use of various literature
and online references results in different
recommendations for drug dose adjustment in renal
disease in very elderly primary care patients.
Methods
Patients and patient data
We included primary care patients aged 80 years and older,
enlisted to 11 participating family practices in Bavaria, a
federal state in southern Germany. We recruited practices
by sending a letter of inquiry to the 120 teaching practices
associated to the Insitute of General Practice at the Tech-
nical University Munich. Eleven practices agreed to par-
ticipate. The practices were instructed to ask their
patients 80 years and older if they would participate in this
study. Every practice was supposed to choose at least ten
patients. Patients were examined in practice, at home
visits in their residence or in their nursing homes. We ex-
cluded patients unable to provide full informed consent,
with thyroid dysfunction not normalized with treatment,
with high dose corticosteroid therapy or with cancer, be-
cause serum cystatin C levels are influenced by these fac-
tors. As patients had to be able to give written informed
consent, only patients without evidence of dementia were
included. Blood samples were drawn for measuring
cystatin C, creatinine, and thyroid-stimulating hormone
(TSH). In addition, body height, weight, prescribed medi-
cation and diagnoses (coded according to the Inter-
national Classification of Diseases (ICD)) were collected
as documented in the physicians’ patient chart. All partici-
pants gave written informed consent.
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the Medical Faculty of the Technical University Munich.
Laboratory measurements
A particle-enhanced immuno-nephelometric assay (Prospec
Siemens) was used for measuring cystatin C levels, a col-
orimetric method for measuring creatinine levels, an en-
zymatic UV-Test (Urease IGLDH, Roche Cobas 8000) for
measuring urea levels. Sodium and potassium levels were
determined indirectly by ionselective electrodes (Roche
Cobas 8000) and TSH levels by an electrochemical lumi-
nescence immunoassay (Roche Cobas e 411). Blood count
was analysed using a Sysmex analyser (XE 2100).
Estimation of glomerular filtration rate
GFR was estimated using two serum creatinine-based
equations and three cystatin C-based equations which
are listed below:
Cockroft-Gault equation:













 0:742 for women

[3]
Grubb equation:eGFRml=min=1:73m2 ¼ 84:69 cystatin Cmg=l−1:680
0:948 if femaleð Þ [14]
Hoek equation:eGFRml=min=1:73m2 ¼ −4:32þ 80:35=cystatin Cmg=l [13]
Perkins equation:eGFRml=min=1:73m2 ¼ 100=cystatin Cmg=l [15]
Serum creatinine-based equations were the CG equation
[4] (adjusted for body surface area by the DuBois formula
[23]: BSAm2 ¼ 0; 007184 height0:725cm  weight0:425kg ) and
the abbreviated (4-variable) MDRD [3]. The cystatin C-
based eGFR-equations were the Grubb equation [14], the
Hoek equation [13], and the Perkins equation (Simple
Cystatin C formula) [15]. The CG and MDRD equation
were chosen because they are commonly in use and well
known to practitioners. Two cystatin C-based equations
(Hoek and Grubb) were chosen because they weredeveloped on data from European study populations and
therefore seemed suitable for our study population. The
Perkins equation was chosen because its use would be
practical for daily use also on home visits as it can easily be
calculated on a pocket calculator because of its simplicity.
Verification of drug dose adjustment to renal function
For each eGFR-value, each patient’s drug doses of his or
her actually prescribed medication according to estimated
renal function were verified using several literature refer-
ences. In our study, five different references, mentioned in
the Background section were consulted. We chose refer-
ences that are easily accessible and commonly used in
daily clinical practice: (e.g. in the U.S. [18], in Great Britain
[19,20] and in Germany [21,22]). More extensive pharma-
ceutical literature references were not included as we
aimed to examine tools that are suitable for daily use in
medical practice. Essential changes in drug doses or discon-
tinuation of medication were documented and compared in
terms of estimated renal function as a consequence of the
different eGFR-equations.
Each participating family practice received a detailed re-
port about every single patient including results of labora-
tory tests, estimated kidney function according to different
equations and recommendations on adjustment of the
prescribed drugs according to eGFR results and literature
recommendations. We did not assess if participating fam-
ily practitioners implemented our recommendations.
Statistical analysis
All statistical analyses were performed using SPSS statis-
tical software (SPSS 18.0 and 19.0, IBM, Somers, NY).
Patient data was summarized descriptively (percentage,
mean, median standard deviations and minimum/max-
imum). We created scatter plots to graphically examine
concordance between the different eGFR estimations, in-
cluding a linear trend regression as well as a bisecting line.
Concordance was further analysed by calculating intra-class
correlation coefficients (ICCs, two-way mixed model) along
with a respective 95% confidence interval. Comparisons
concerning the numbers of drugs that may require dose
adjustments were done using the two-sided Friedman- or
Wilcoxon-test, as appropriate. Agreement beyond chance
between different literature and online sources regarding
the necessity of drug dose adjustment was quantified with
kappa statistic. Kappa values < 0.4 were considered as low
agreement, values between 0.4 to 0.59 as moderate, 0.6 to
0.74 as good and higher as very good agreement.
Results
A total of 108 patients, 73% female with a mean age of
85 years, were included in the study. The number of pa-
tients enlisted from each individual practice ranged from
one to 25 patients. On average five patients per practice
Table 2 Most common diagnoses as documented in
patient charts as coded in ICD 10
N = 108 N (%)
Hypertension 94 (87)
Arthrosis 58 (54)
Cardiac failure 54 (50)
Hyperlipidemia 49 (45)
Type 2 diabetes mellitus 43 (40)
Coronary heart disease 35 (32)
Chronic kidney failure (no dialysis required) 32 (30)
Hyperuricemia 29 (27)
Atrial fibrillation 28 (26)
Depression 21 (19)
Incontinence 21 (19)
Peripheral artery occlusive disease 21 (19)
Struma 19 (18)
Dementia 13 (12)
Chronic obstructive pulmonal disease (COPD) 12 (11)
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and drugs, and laboratory measures are summarized in
Tables 1, 2 and 3. Chronic kidney failure was docu-
mented a priori for 32 patients (30%) in the general
practitioners´ patient records. It was not possible to de-
termine if drug dose adjustment was done before by the
general practitioners in that group due to kidney func-
tion or due to other reasons. The three most frequent
diagnoses (prevalence over 50%) were hypertension, ar-
throsis and cardiac failure. Due to exclusion of patients
unable to provide written informed consent, the propor-
tion of patients suffering from dementia and the propor-
tion of patients taking psychotropic substances were
comparatively low. Most commonly taken remedies (taken
by more than 50% of the patients) were angiotensin-
converting enzyme inhibitors, hydrochlorothiazide and
beta-adrenoceptor blockers. Some of these drugs may re-
quire drug dose adjustment in renal impairment as shown
in Table 3.
The lowest median estimate of renal function resulted
from the use of the creatinine-based CG and MDRD
equations and the highest from the cystatin C-based
Perkins-equation (Table 1, lower section). High concord-
ance was observed between the creatinine-based equa-
tions alone and between the cystatin C-based equations
alone (Table 4). Concordance between creatinine-based
equations and cystatin C-based equations was moderate.
Scatterplots illustrating the relation between the results
of the two creatinine-based and the three cystatin C-
based equations are presented in Figure 1. Concordance
was highest between the creatinine-based equations and
the Hoek equation, and lowest between the creatinine-
based equations and the Grubb equation.
When comparing the five different references consulted
to identify necessary drug dose adjustment in relation to
the estimated kidney function, we found that the numberTable 1 Physical and biochemical patient characteristics
N = 108 N (%) or Median (range)
Female sex 79 (73)
Age (years) 85 (80–102)
Body Mass Index (kg/m2) 26.0 (16.7-47.1)
Number of diagnoses 9 (2–17)
Number of drugs/day 7 (1–19)
Creatinine (mg/dl) 1.0 (0.5-3.2)
Cystatin C (mg/l) 1.2 (0.6-3.4)
eGFR Cockroft-Gault (ml/min/1,73 m2) 45.3 (12.2-95.8)
eGFR MDRD (ml/min/1,73 m2) 53.2 (14.8-118.1)
eGFR Grubb (ml/min/1,73 m2) 63.5 (11.1-174.5)
eGFR Hoek (ml/min/1,73 m2) 65.5 (19.7-123.2)
eGFR Perkins (ml/min/1,73 m2) 87.0 (29.9-158.7)of drugs that necessitate a dose adjustment in case of renal
impairment differ considerably (Table 5). “Drug Prescrib-
ing in Renal Failure” and “Arzneimittel Pocket” identify
the highest number of drugs which need to be adjusted
following renal impairment. None of the literature refer-
ences contained information on all drugs taken by the
study patients.
Agreement and disagreement in recommendations re-
garding the number of medication changes according to
the different literature and online references is exemplarily
shown for the results of the CG equation in Table 6. If a
literature reference did not provide information about
drug dose adjustment for a certain drug, we rated it as “no
change necessary”. This approach was chosen because we
assumed that a practitioner would not adjust the drug
dose in that case. Kappa values ranged between 0.10 and
0.62 with the majority of values below 0.40 (indicating low
agreement beyond chance).Testing Kappa coefficients with
regard to other eGFR estimations yielded similar results.
Descriptive analysis also shows differences in recommen-
dations according to literature references (not shown in
table). For example, according to “The Renal Drug Hand-
book” a change of drug prescription is recommended in 6
to 12 patients depending on the formula used, while
according to “Drug Prescribing in Renal Failure” the num-
ber of patients varies between 21 and 27. In addition, par-
tially conflicting recommendations were found.
Discussion
We found that cystatin C-based equations resulted
in more optimistic estimations of kidney function than
the creatinine-based ones. However, variations in
Table 3 Most commonly taken remedies
N = 108 N (%)
Angiotensin-converting enzyme inhibitor* 59 (55)
Hydrochlorothiazide* 59 (55)
Beta-adrenoceptor blocker** 54 (50)
Acetylsalicylic acid* 41 (38)





Allopurinol* 10 ( 9)
Bisphosphonates* 8 ( 7)
Neuroleptics** 8 ( 7)
Sulfonylureas* 8 ( 7)
Acetaminophen (Paracetamol)* 7 (.7)
Metformin* 7 ( 7)
Metoclopramide* 7 ( 7)
Aldosterone antagonists* 4 ( 4)
Antidementives** 2 ( 2)
Antiepileptics** 2 ( 2)
Alpha2 adrenergic receptor antagonists* 2 ( 2)
Digoxin* 2 ( 2)
H2 receptor antagonists* 2 ( 2)
Disease modifying antirheumatic drugs** 2 ( 2)
* All drugs in this class require dose adjustment in case of moderate or severe
renal impairment.
** Some drugs of this class require dose adjustment in case of
renal impairment.
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sources led to more variations in drug dose adjustment
than the different GFR-equations alone.
In general creatinine-based equations resulted in a
lower eGFR-estimation and in a higher necessity of drug
dose adjustment than Cystatin C-based equations. The
CG equation resulted in the lowest and the Perkins
equation in the highest estimation of kidney-function.
Several trials showed that kidney function in elderly pa-
tients is estimated to be lower or even underestimated
by the CG equation compared to the 4-variable MDRDTable 4 Intraclass-correlation coefficients for eGFR according
eGFR (ml/min/1.73 m2) CG (95% CI) Hoek (




CG = Cockroft-Gault; MDRD =Modification of Diet in Renal Disease;
95% CI = 95% confidence interval.equation [2,7,24,25]. Results concerning differences in
accuracy of CG and MDRD equations in senior patients
are inconsistent. Some trials showed higher precision for
MDRD than CG when compared with a reference stand-
ard [25-27]. Other studies using a reference standard
found a lack of precision in both formulas in elderly pa-
tients [6,24].
There is little data about the use of cystatin C-based
GFR-equations in very old patients. Systematic reviews
comparing several studies about diagnostic accuracy of
serum cystatin C and serum creatinine for diagnosing
renal failure found more studies favouring cystatin C, or
describing cystatin C as equal, than those favouring cre-
atinine [28,29]. A systematic review [30] analysed 12
studies comparing serum creatinine, CG equation,
MDRD equation, serum cystatin C and several different
GFR equations with a reference standard in elderly pa-
tients aged 65 years and older. The CG and MDRD
equations and the serum cystatin C equations produced
the highest correlations with the reference standard.
Serum creatinine correlated poorly with the reference
standard and therefore appeared to be an insensitive tool
for measuring renal function in the elderly.
The impact on drug dose adjustment in four defined
drug classes (metformin, nonsteroidal anti-inflammatory
drugs, angiotensin-converting-enzyme-inhibitors/angioten-
sin receptor blockers, and digoxin) depending on different
equations was analysed in a Swedish study [17]. As men-
tioned above, this study also found a lack of concordance
between MDRD, CG and the Grubb equation, but the in-
vestigated renal risk drugs were rarely prescribed.
In addition to the estimated kidney function, the
chosen literature source had a strong impact on the rec-
ommendations for drug dose adjustment in our study
population. Kappa coefficients reveal a lack of accord-
ance between the recommendations according to the
various literature sources. Depending on the literature
source, different numbers of drugs are to be adjusted
following renal impairment. Also the recommendations
concerning critical values of GFR requiring drug dose
adjustment differed considerably among the different
sources. The use of “Arzneimittel Pocket” resulted in the
highest number of advised modifications of medication
and the use of “The Renal Drug Handbook” in theto different equations
95% CI) Grubb (95% CI) Perkins (95% CI)
.66-0.83) 0.65 (0.53-0.75) 0.73 (0.63-0.81)
.57-0.78) 0.54 (0.39-0.66) 0.63 (0.50-0.73)
0.90 (0.85-0.93) 0.98 (0.97-0.98)
0.96 (0.95-0.98)
Figure 1 Scatter plots illustrating the relation between the results of the two creatinine-based and the three cystatin C-based
equations. Figure Legend: R2 Linear: linear regression coefficient. CG = Cockroft Gault; MDRD =Modification of Diet in Renal Disease.
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ging to such an extent. Three of the literature sources
(The Renal Drug Handbook, Arzneimittel Pocket and
Dosing) have been written by one or more authors and
two (British National Formulary and Drug Prescribing in
Renal Failure) have been developed by expert panels. All
authors point out that they are referring to the newest evi-
dence. The broad variation of results of estimated kidney
function and of the recommendations given in different
literature and online sources creates an uncertainty for the
practitioner. The extent of the risk potential resulting from
medication with renal risk drugs for the elderly is unclear.
For daily practice it seems reasonable to use the CG
equation as a more conservative approach to dose ad-
justment in renal impairment. But it is important to
keep in mind that there is a risk of underdosing due tothe fact that the CG equation tends to underestimate kid-
ney function in the elderly. In borderline cases (e.g. if a
drug should be reduced in the case of an eGFR of less than
30 ml/min/1.73 m2 and the use of CG is resulting in an
eGFR of 29 ml/min/1.73 m2) another equation should be
used for control. In this case MDRD would work well. In
cases where kidney function is over 60 ml/min/1.73 m2, a
cystatin C-based formula could be used. The use of the
Grubb equation makes sense in this case, as it is resulting
in a more conservative estimation of kidney function. But
we cannot give a clear recommendation, as there are many
other creatinine- and cystatin C-based equations that have
not been examined in our study.
Regarding the literature recommendations it appears
difficult to suggest the use of one particular literature
reference since none of the references is covering all of
Table 5 Differences in the number of drugs that may require dose adjustment in kidney failure per patient according
to the five literature sources
Nr. of Drugs Renal Drug HB Dosing AMP BNF DPRF
0 7 (6%) 4 (13%) 9 (8%) 11 (10%) 7 (7%)
1 37 (34%) 19 (18%) 18 (17%) 23 (21%) 16 (15%)
2 33 (31%) 40 (37%) 28 (26%) 40 (37%) 34 (32%)
3 21 (19%) 25 (23%) 36 (33%) 25 (23%) 31(29%)
4 9 (8%) 7 (6%) 13 (12%) 7 (7%) 12 (11%)
5 1 (1%) 3 (3%) 3 (3%) 1 (1%) 5 (5%)
6 1 (1%) 0 (0%) 3 (3%)
7 1 (1%)
M (SD) 1.92 (1.10) 2.01 (1.20) 2.36 (1.26) 2.02 (1.20) 2.48 (1.34)
Friedman-test for comparison of all literature sources: p < 0.001; Wilcoxon-test paired samples: p < 0.001 for Renal Drug HB vs. AMP, Dosing vs. AMP, Renal Drug
HB vs. DPRF, Dosing vs.DPRF, AMP vs. BNF, BNF vs. DPRF, and p = 0.39 for Renal Drug HB vs. Dosing, p = 0.36 for RDB vs. BNF, p = 0.95 for Dosing vs. BNF, p = 0.22
for AMP vs. DPRF;
M =Mean, SD = Standard deviation;
Renal Drug HB = The Renal Drug Handbook (19), Dosing = www.dosing.de (21), AMP = Arzneimittel Pocket (22), BNF = British National Formulary (20), DPRF = Drug
Prescibing in Renal Failure (18).
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lated references as they are the most likely to coincide
with national guidelines.
A strength of our study is that it was conducted under
conditions of routine practice and focused on the conse-
quences for the daily work of a family physician. We ex-
amined patients at eighty years of age and older because
multimorbidity, polypharmacy and renal impairment are
common in this group of patients and, according to lit-
erature, it remains unclear which eGFR-estimation is
suitable for estimating kidney function. The four litera-
ture references and the online-source analysed are easily
accessible for practitioners and commonly in use. There
are differences in the estimated prevalence of impaired
renal function depending on the eGFR-equation applied,Table 6 Agreement beyond chance (Kappa coefficients)
among different references regarding necessary drug
changes when using the Cockroft-Gault equation for
estimating eGFR
Dosing AMP BNF DPRF
(95% CI) (95% CI) (95% CI) (95% CI)
Renal Drug HB 0.15 0.10 0.23 0.20
(0.00-0.32) (0.00-0.34) (0.06-0.40) (0.03-0.36)






95% CI = 95% confidence interval;
Renal Drug HB = The Renal Drug Handbook (19), Dosing = www.dosing.de
(21), AMP = Arzneimittel Pocket (22), BNF = British National Formulary (20),
DPRF = Drug Prescibing in Renal Failure (18).and reduced kidney function seems to be common in
our study population. A limitation of our study is that
kidney function was not determined by inulin-clearance,
51Cr-EDTA-clearance, or iohexol-clearance, which are
reference standards. However, this was not possible in
the primary care setting. But this could not hamper our
results related to the heterogeneity of eGFR equations
which are originally derived by validation compared to a
reference standard. Another limitation is that patients
included had to be able to give written informed con-
sent, therefore patients suffering from dementia or se-
vere frailty, could not be examined. As a result, our
study population is not fully representative for the age
group as the examined patients were in relatively good
mental condition. Another limitation of the study may
be that we restricted the number of literature references
on drug dose adjustment in renal failure to five com-
monly in use. However, we explicitly wanted to examine
practice conditions and examine tools that are easy to
apply and can also be used on home visits.
Conclusions
The chosen literature references resulted in bigger dif-
ferences in recommendations for drug dose adjustment
than the different equations used for estimating eGFR
alone. Both, the divergent results of the eGFR equations
and the conflicting instructions according to the litera-
ture sources can lead to uncertainty for the practitioner
and as a result compromise patient safety. Thus there is
a strong need for a validated eGFR-equation for estimat-
ing kidney function in the elderly. Further research on
estimation of GFR and the development of an inter-
national consensus on concordant recommendations for
practitioners concerning drug dose adjustment in renal
failure are desirable.
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